Employee-related Liabilities, Current in USD of ABVC BIOPHARMA, INC. from Q4 2023 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
Abvc Biopharma, Inc. quarterly Employee-related Liabilities, Current history and change rate from Q4 2023 to Q3 2025.
  • Abvc Biopharma, Inc. Employee-related Liabilities, Current for the quarter ending 30 Sep 2025 was $155K, a 72.2% increase year-over-year.
Employee-related Liabilities, Current, Quarterly (USD)
Employee-related Liabilities, Current, YoY Quarterly Change (%)

ABVC BIOPHARMA, INC. Quarterly Employee-related Liabilities, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $155K +$64.9K +72.2% 30 Sep 2025 10-Q 03 Nov 2025
Q2 2025 $161K -$1.08M -87.1% 30 Jun 2025 10-Q 13 Aug 2025
Q1 2025 $140K -$921K -86.8% 31 Mar 2025 10-Q 30 Apr 2025
Q4 2024 $126K +$97K +333% 31 Dec 2024 10-Q 03 Nov 2025
Q3 2024 $89.9K 30 Sep 2024 10-Q 14 Nov 2024
Q2 2024 $1.24M 30 Jun 2024 10-Q 14 Aug 2024
Q1 2024 $1.06M 31 Mar 2024 10-Q 17 May 2024
Q4 2023 $29.1K 31 Dec 2023 10-K 15 Apr 2025
* An asterisk sign (*) next to the value indicates that the value is likely invalid.